NASDAQHealth CareMedical Instruments & SuppliesSnapshot 2026-07-23
Reading LMAT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a stable growth opportunity in the healthcare sector. The current thesis state is intact, driven by recent earnings performance and management's focus on revenue growth and operating income enhancement.
The market currently prices LMAT at a premium compared to its peers, reflecting elevated expectations. However, there is an expectations gap, indicating that some future performance improvements may not be fully justified by current valuations.
Management has consistently communicated priorities around revenue growth, operating income, and increasing dividends, all of which are on track. While recent financial performance has been strong, there is a moderate risk of missing future estimates due to past performance issues.
The long-term thesis hinges on the performance of sector bellwethers like ISRG, MDLN, and BDX. If these companies continue to perform well, LMAT may benefit from the healthcare sector's momentum; however, any negative shifts in their performance could impact LMAT adversely.
Overall, LMAT's outlook remains stable, but investors should monitor sector trends and company performance closely. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. This improvement is driven by the latest earnings beat, which indicates that the company's financial performance remains strong. There are no current threats impacting the thesis.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Keeping the dividend shows a commitment to shareholders. It shows financial strength.
Confirms:The quarterly dividend remains at $0.25 per share.
Disproves:The quarterly dividend is reduced below $0.25 per share.
Why it matters: Sales below this level would signal weaker growth than expected. This could raise concerns about demand and market position.
Confirms:Q2 2026 sales reported below $70.5 million.
Disproves:Q2 2026 sales reported above $72.5 million.
Why it matters: Changes can affect strategy and management. This may impact investor trust.
Confirms one read:Announcement of a new director or board member.
Confirms the other:No new appointments or further departures from the Board.
Why it matters: Meeting this growth target would show LeMaitre is on track with its revenue goals. It would also help offset recent earnings concerns.
Confirms:Q2 revenue growth meets or exceeds 10% year over year.
Disproves:Q2 revenue growth falls below 5% year over year.
Why it matters: Better margins show good cost control. This helps increase operating income.
Confirms:Operating income margin is over 27% in Q2.
Disproves:Operating income margin drops below 25% in Q2.
Why it matters: Updates on share buybacks may show management's trust in the stock's value.
Confirms:They announced share buybacks worth over $25 million.
Disproves:No updates or repurchases reported by the end of Q2 2026.
Why it matters: A drop below median growth would signal a slowdown in the sector's expansion.
Confirms:Revenue growth falls below the median of 10% year over year.
Disproves:Revenue growth remains at or above the median of 10% year over year.
Why it matters: If operating income is below this level, it shows cost management problems. This may hurt investor trust in profits.
Confirms:In Q2 2026, operating income was below $20.8 million.
Disproves:In Q2 2026, operating income was above $22.3 million.
Why it matters: An increase would show commitment to returning value to shareholders. This could enhance investor sentiment.
Confirms:Announcement of a dividend increase above $0.25 per share.
Disproves:No increase in the dividend for Q3 2026.
Why it matters: A drop below this level would suggest rising costs or pricing pressures. This could impact overall profitability.
Confirms:Q2 2026 gross margin reported below 72.1%.
Disproves:Q2 2026 gross margin reported above 72.3%.
